NexImmune Inc (NEXI)
3.37
-0.01
(-0.30%)
USD |
NASDAQ |
May 09, 12:07
NexImmune Net Income (Quarterly): -5.359M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -5.359M |
September 30, 2023 | -9.854M |
June 30, 2023 | -7.566M |
March 31, 2023 | -9.565M |
December 31, 2022 | -16.89M |
September 30, 2022 | -14.73M |
June 30, 2022 | -15.86M |
March 31, 2022 | -15.02M |
December 31, 2021 | -15.53M |
Date | Value |
---|---|
September 30, 2021 | -14.65M |
June 30, 2021 | -12.18M |
March 31, 2021 | -8.547M |
December 31, 2020 | -8.011M |
September 30, 2020 | -8.609M |
June 30, 2020 | -6.930M |
March 31, 2020 | -6.316M |
December 31, 2019 | -5.122M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-16.89M
Minimum
Dec 2022
-5.122M
Maximum
Dec 2019
-10.63M
Average
-9.565M
Median
Mar 2023
Net Income (Quarterly) Benchmarks
Mind Medicine Inc | -23.86M |
Candel Therapeutics Inc | -11.10M |
Rani Therapeutics Holdings Inc | -7.098M |
Ventyx Biosciences Inc | -46.75M |
GRI Bio Inc | -2.004M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 4.677M |
EPS Diluted (Quarterly) | -4.99 |
Enterprise Value | -0.0122M |
Earnings Yield | -916.6% |